食品伙伴网讯�?a href='//www.sqrdapp.com/news/tag_1377.html' class='zdbq' title='欧盟食品安全局相关食品资讯' target='_blank'>欧盟食品安全局消息，欧盟食品安全局� 2015 � 2 � 26 日就��L-tug番茄红素有助于降低血液低密度脁�a href='//www.sqrdapp.com/news/tag_3855.html' class='zdbq' title='蛋白相关食品资讯' target='_blank'>蛋白胆固醆�/a>��皃�a href='//www.sqrdapp.com/news/tag_896.html' class='zdbq' title='健康声称相关食品资讯' target='_blank'>健康声称发布科学建议、�/p>

欧盟食品安全局对文献资料进行审查认为，目前数据不充分，尚未有因果关系来表明 L-tug 番茄红素有助于降低血液低密度脂蛋白胆固醇。L-tug 技术主要应用于动植物脂肪以及巧克力。可用于防止肝脏餐后代谢应激、瞬态高胆甾醇血等、�/p>

部分原文报道如下９�/p>

Following an application from Lycotec Ltd, submitted pursuant to Article 14 of Regulation （EC� No 1924/2006 via the Competent Authority of the United Kingdom, the Panel on Dietetic Products, Nutrition and Allergies （NDA� was asked to deliver an opinion on the scientific substantiation of a health claim related to ��L-tug lycopene�� and reduction of blood low-density lipoprotein （LDL�?cholesterol. The food constituent that is the subject of the claim is L-tug lycopene （i.e. Lyc-O-Mato? embedded in fat-rich matrices by a manufacturing process claimed as proprietary and confidential by the applicant）� The Panel considers that the food constituent, L-tug lycopene, which is the subject of the claim, is sufficiently characterised.

原文链接９�a href="http://www.efsa.europa.eu/en/efsajournal/pub/4025.htm">http://www.efsa.europa.eu/en/efsajournal/pub/4025.htm